Skip to content
Finance Investment, Oil Mining Resources

Locksley Resources Leading the Charge for 100% Made-in-America Antimony

Jane Morgan Management 2 mins read

Locksley Resources Ltd. (ASX: LKY | OTCQX: LKYRF) is advancing a critical milestone in re-establishing the United States’ domestic antimony supply chain through its Desert Antimony Mine (DAM), a high-grade primary stibnite deposit located within the Mojave Project in California.

The United States currently has no operating primary antimony mine and remains almost entirely dependent on imports from China and Russia for this critical mineral, which is essential for defense, energy storage, and semiconductor manufacturing. Locksley’s clean, high-grade concentrate and streamlined development pathway position the Company to deliver a genuinely “Made in America” solution for antimony sourcing and processing.

A key distinction sets Locksley apart. Primary antimony deposits such as DAM differ fundamentally from deposits where antimony is recovered only as a by-product of gold or base-metal mining. The DAM Project represents a stibnite-dominant system with straightforward metallurgy, lower capital intensity, and the potential for rapid development. Using an iron-ore analogy helps illustrate the point: most of the world’s antimony supply resembles magnetite or blended ores (complex, capital-intensive, and slow to develop) whereas Locksley’s DAM Project is akin to hematite DSO: clean, high-grade, and simple to process. This is precisely the type of feedstock required to secure and accelerate America’s domestic antimony supply chain.

Recent metallurgical testwork at DAM produced a 68.1% antimony concentrate, equating to 95% of the theoretical stibnite grade, confirming simple flotation processing and minimal impurities. The results demonstrate that DAM can deliver a high-purity concentrate suitable for fast-tracked production using modular, scalable plants.

Locksley’s development strategy aligns with key U.S. government initiatives designed to onshore critical mineral supply chains, including programs under the Defense Production Act Title III, DOE ARPA-E, and EXIM Bank. Unlike polymetallic deposits that require complex circuits and longer permitting timelines, the DAM Project’s clean, primary stibnite feed provides an ideal complement to larger, multi-metal developments by offering near-term, high-grade antimony supply.

Collaborations with leading U.S. stakeholders, including Rice University and GreenMet, are supporting downstream processing initiatives aimed at producing the first domestically sourced antimony ingot in decades. Through this integrated approach, Locksley is helping build the foundation for a secure, traceable, and fully domestic supply chain capable of serving America’s defense, energy, and industrial needs.

Locksley Chairman, Nathan Lude commented:

“Locksley is leading the charge to rebuild America’s antimony supply chain from the ground up. By combining high-grade domestic feedstock with innovative U.S. processing, we’re positioning the Mojave Project to deliver 100% Made-in-America antimony, a critical step toward securing the nation’s defense, energy, and industrial future.”

Locksley’s overarching goal is to become the U.S. beachhead for mining, sourcing, and processing of antimony within America. By combining clean mineralogy, low-cost metallurgy, and proximity to established infrastructure in a Tier-1 jurisdiction, the Company is driving toward the delivery of a 100% Made-in-America product - rebuilding an essential component of the nation’s critical mineral independence.


About us:

About Locksley Resources Limited 

Locksley Resources Limited is an ASX listed explorer focused on critical minerals in the United States of America. The Company is actively advancing exploration across two key assets: the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley Resources aims to generate shareholder value through strategic exploration, discovery and development in this highly prospective mineral region.

 


Contact details:

Jane Morgan – Investor & Media Relations
 [email protected]
+61 405 555 618

Media

More from this category

  • Finance Investment
  • 27/01/2026
  • 23:11
Axi Trader LLC

Axi Select Expands Pro M Ranks to 10 as Global Trader Community Surpasses 49,000

SYDNEY, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Leading online FX and CFD broker Axi has shared that 10 traders worldwide have now reached the $1M Pro M level in Axi Select - the broker's flagship capital allocation program - marking a major milestone as the program’s global trading community surpasses 49,000 participants.The growth reflects the continued momentum of Axi Select, a performance-based capital allocation program designed to support traders with a clear, structured pathway toward managing meaningful levels of capital. Pro M represents the program’s top tier, providing qualified traders with the opportunity to manage up to USD $1,000,000 in…

  • Finance Investment, Oil Mining Resources
  • 27/01/2026
  • 10:46
Jane Morgan Management

QPM Energy Secures Key Grid Connection Agreement with Powerlink Queensland for Isaac Power Station

QPM Energy Limited (ASX: QPM) has executed a Connection Project Delivery Agreement (CPDA) with Powerlink Queensland, marking a major milestone in the development of its 112-megawatt Isaac Power Station in central Queensland. The agreement enables Powerlink to commence construction works at its Moranbah substation, a critical step toward connecting the Isaac Power Station to the Queensland electricity network. Execution of the CPDA is also a key requirement for completion of the project’s finance facility. Under the CPDA, Powerlink will progress connection works ahead of issuing an Offer to Connect under Chapter 5 of the National Electricity Rules. The agreement incorporates…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 27/01/2026
  • 10:13
Jane Morgan Management

Nexsen secures $500,000 Federal grant to expand rapid GBS diagnostics into neonatal care

27 January 2026 – Melbourne, Australia | Nexsen Limited (ASX:NXN) has secured a $500,000 non-dilutive Federal Government grant to expand its rapid point-of-care diagnostic platform into neonatal testing, significantly broadening the commercial and clinical scope of its Group B Streptococcus (GBS) program for a materially larger opportunity for testing. The funding has been awarded to RMIT University under the Commonwealth’s Australia’s Economic Accelerator (AEA) Ignite program, with Nexsen appointed as the industry commercialisation partner. The project, titled “Transforming Neonatal Care with a Rapid Diagnostic for Group B Streptococcus (GBS)”, has a total value exceeding $1 million. The initiative will support…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.